Dianthus Therapeutics
DNTH
DNTH
101 hedge funds and large institutions have $728M invested in Dianthus Therapeutics in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 39 reducing their positions, and 14 closing their positions.
Holders
101
Holders Change
+3
Holders Change %
+3.06%
% of All Funds
1.36%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
18
Increased
29
Reduced
39
Closed
14
Calls
$2.1M
Puts
$93K
Net Calls
+$2.01M
Net Calls Change
+$2.93M
Top Buyers
1 |
VPC
1
Vestal Point Capital
New York
|
$59.6M |
2 |
BBA
2
Baker Bros. Advisors
New York
|
$14.7M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$26.9M |
4 |
4
Goldman Sachs
New York
|
$6.79M |
5 |
5
Millennium Management
New York
|
$3.64M |